Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Pharmacogenomics and Personalized Medicine
|
May 27, 2017
<i>ABCB1</i> genetic variants in leukemias: current insights into treatment outcomes
Ravindran Ankathil
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 6, 2015
Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes
Shing Cheng Tan, Ravindran Ankathil
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 18, 2011
Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection
Ka Liong Tan, Ravindran Ankathil, Siew Hua Gan
Journal of Maxillofacial and Oral Surgery
|
August 19, 2021
Next-Generation Sequencing in Cancer
S Vinod Nair, Madhulaxmi, Gigi Thomas, et al.
Journal of Genetics
|
September 29, 2018
Genetic variations in influx transporter gene <i>SLC22A1</i> are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients
Siti Maziras Makhtar, Azlan Husin, Abdul Aziz Baba, et al.
Cardiovascular & Hematological Disorders Drug Targets
|
April 20, 2018
Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients
Marjanu Hikmah Elias, Husin Azlan, Abdul Aziz Baba, et al.
Pharmacogenomics
|
March 24, 2018
Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update
Ravindran Ankathil, Husin Azlan, Abu Abdullah Dzarr, et al.
International Journal of Breast Cancer
|
April 21, 2020
Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
Ahmad Aizat Abdul Aziz, Md Salzihan Md Salleh, Ravindran Ankathil
Journal of Genetics
|
September 27, 2017
Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients
Siti Maziras Makhtar, Azlan Husin, Abdul Aziz Baba, et al.
Cancer Reports (Hoboken, N.J.)
|
July 29, 2020
Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients
Marjanu Hikmah Elias, Husin Azlan, Sarina Sulong, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Pharmacogenomics and Personalized Medicine
|
May 27, 2017
<i>ABCB1</i> genetic variants in leukemias: current insights into treatment outcomes
Ravindran Ankathil
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 6, 2015
Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes
Shing Cheng Tan, Ravindran Ankathil
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
October 18, 2011
Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection
Ka Liong Tan, Ravindran Ankathil, Siew Hua Gan
Journal of Maxillofacial and Oral Surgery
|
August 19, 2021
Next-Generation Sequencing in Cancer
S Vinod Nair, Madhulaxmi, Gigi Thomas, et al.
Journal of Genetics
|
September 29, 2018
Genetic variations in influx transporter gene <i>SLC22A1</i> are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients
Siti Maziras Makhtar, Azlan Husin, Abdul Aziz Baba, et al.
Cardiovascular & Hematological Disorders Drug Targets
|
April 20, 2018
Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients
Marjanu Hikmah Elias, Husin Azlan, Abdul Aziz Baba, et al.
Pharmacogenomics
|
March 24, 2018
Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update
Ravindran Ankathil, Husin Azlan, Abu Abdullah Dzarr, et al.
International Journal of Breast Cancer
|
April 21, 2020
Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
Ahmad Aizat Abdul Aziz, Md Salzihan Md Salleh, Ravindran Ankathil
Journal of Genetics
|
September 27, 2017
Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients
Siti Maziras Makhtar, Azlan Husin, Abdul Aziz Baba, et al.
Cancer Reports (Hoboken, N.J.)
|
July 29, 2020
Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients
Marjanu Hikmah Elias, Husin Azlan, Sarina Sulong, et al.
Page
of 6